LeadIQ logo
Learn more at LeadIQ.com

Insights

Cell Therapy Expansion BlueRock Therapeutics is a pioneer in developing iPSC-derived cell therapies for ocular diseases, presenting a sales opportunity for partnering with healthcare institutions and clinics looking to offer cutting-edge regenerative treatments.

Regenerative Medicine Advancements With FDA's RMAT designation for bemdaneprocel in treating Parkinson's disease, BlueRock Therapeutics showcases potential sales prospects in engaging with pharmaceutical companies and research institutions interested in innovative regenerative medicine solutions.

Strategic Partnerships Collaborations with industry leaders like FUJIFILM, Opsis Therapeutics, and Cytiva demonstrate BlueRock Therapeutics' commitment to innovation, opening doors for sales discussions with technology providers and research organizations seeking strategic partnerships.

Market Expansion BlueRock's focus on T cell therapies and strategic alliances for developing cell therapies for eye diseases indicates a growing market presence, offering sales opportunities for suppliers of bioprocessing equipment, laboratory consumables, and cell culture technologies.

Financial Stability and Growth With a healthy revenue range of $50M - 100M and significant funding of $225M, BlueRock Therapeutics presents a strong potential for sales engagements with investors, financial institutions, and service providers looking to support a financially stable and growing biotechnology company.

Similar companies to BlueRock Therapeutics

BlueRock Therapeutics Tech Stack

BlueRock Therapeutics uses 8 technology products and services including SAS/GRAPH, WordPress, Microsoft Dynamics 365, and more. Explore BlueRock Therapeutics's tech stack below.

  • SAS/GRAPH
    Business Intelligence
  • WordPress
    Content Management System
  • Microsoft Dynamics 365
    Enterprise Resource Planning
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Backbone.js
    Javascript Frameworks
  • Snap.svg
    Javascript Libraries
  • prettyPhoto
    Javascript Libraries
  • Coupa
    Travel And Expense Management

Media & News

BlueRock Therapeutics's Email Address Formats

BlueRock Therapeutics uses at least 1 format(s):
BlueRock Therapeutics Email FormatsExamplePercentage
FLast@bluerocktx.comJDoe@bluerocktx.com
95%
FL@bluerocktx.comJD@bluerocktx.com
3%
LastF@bluerocktx.comDoeJ@bluerocktx.com
2%

Frequently Asked Questions

Where is BlueRock Therapeutics's headquarters located?

Minus sign iconPlus sign icon
BlueRock Therapeutics's main headquarters is located at 238 Main St Cambridge, Massachusetts 02142 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is BlueRock Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
BlueRock Therapeutics's official website is bluerocktx.com and has social profiles on LinkedIn.

How much revenue does BlueRock Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, BlueRock Therapeutics's annual revenue reached $75M.

What is BlueRock Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
BlueRock Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BlueRock Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, BlueRock Therapeutics has approximately 482 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Technology Officer: C. B.Chief Development And Medical Officer: A. R.Chief Scientific Officer: S. I.. Explore BlueRock Therapeutics's employee directory with LeadIQ.

What industry does BlueRock Therapeutics belong to?

Minus sign iconPlus sign icon
BlueRock Therapeutics operates in the Biotechnology Research industry.

What technology does BlueRock Therapeutics use?

Minus sign iconPlus sign icon
BlueRock Therapeutics's tech stack includes SAS/GRAPHWordPressMicrosoft Dynamics 365Twitter Emoji (Twemoji)Backbone.jsSnap.svgprettyPhotoCoupa.

What is BlueRock Therapeutics's email format?

Minus sign iconPlus sign icon
BlueRock Therapeutics's email format typically follows the pattern of . Find more BlueRock Therapeutics email formats with LeadIQ.

How much funding has BlueRock Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, BlueRock Therapeutics has raised $225M in funding. The last funding round occurred on Dec 12, 2016 for $225M.

When was BlueRock Therapeutics founded?

Minus sign iconPlus sign icon
BlueRock Therapeutics was founded in 2016.
BlueRock Therapeutics

BlueRock Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications.

BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function.

BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. 

Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.

Section iconCompany Overview

Headquarters
238 Main St Cambridge, Massachusetts 02142 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
201-500

Section iconFunding & Financials

  • $225M

    BlueRock Therapeutics has raised a total of $225M of funding over 1 rounds. Their latest funding round was raised on Dec 12, 2016 in the amount of $225M.

  • $50M$100M

    BlueRock Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $225M

    BlueRock Therapeutics has raised a total of $225M of funding over 1 rounds. Their latest funding round was raised on Dec 12, 2016 in the amount of $225M.

  • $50M$100M

    BlueRock Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.